Bandingkan Harga & Kinerja Indomobil Multi Jasa Tbk. (IMJS) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Indomobil Multi Jasa Tbk. dan Organon Pharma Indonesia Tbk.: Indomobil Multi Jasa Tbk. diperdagangkan di Rp183 (kapitalisasi pasar 2,02 T, volume 24 jam 2,92 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Indomobil Multi Jasa Tbk. jauh lebih besar — sekitar 19,3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| IMJS | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 2,02 T | 104,4 M |
Volume | 2,92 jt | — |
Lot | 29,25 rb | — |
Perputaran | 530,02 jt | — |
Harga Rata-rata | 181,23 | — |
Nilai Transaksi | 530,02 jt | — |
Harga Ekuilibrium Indikatif | 183 | — |
Volume Ekuilibrium Indikatif | 215 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Indomobil Multi Jasa Tbk.
PT. Indomobil Multi Jasa (the "Company") was established on December 14, 2004 as PT Multi Tambang Abadi (MTA) based on Notarial Deed No.67 of Aulia Taufani, S.H., substitute of Sutjipto, S.H.The Company's articles of assosiation has been amended several times. Based on Notarial Deed No.56 of Ir. Nanette Cahyanie Handari Adi Warsito, S.H., dated February 13, 2013 which has been approved by the Minister of Laws and Human Rights of the Republic od Indonesia in its Decision Letter No. AHU-09669.A.H.01.02. Year 2013 dated February 28, 2013, the articles of association of the Company has been amended concerning among others.
Selengkapnya di halaman IMJS →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
